|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
1
|
Resverlogix Corp.
|
Apr 21, 2021 11:46AM
|
|
Re: As much as I think we're on the cusp......
|
3
|
Resverlogix Corp.
|
Sep 07, 2017 07:34PM
|
|
Re: ASCO 2019 coming up May 31 to June 4
|
3
|
Zenith Epigenetics
|
May 20, 2019 01:34PM
|
|
Re: ASCO 2019 coming up May 31 to June 4
|
4
|
Zenith Epigenetics
|
May 27, 2019 03:38PM
|
|
Re: At least we're getting some intersting trading...
|
4
|
Resverlogix Corp.
|
Mar 09, 2017 10:03AM
|
|
Re: Award of deferred shares and restricted shares
|
13
|
Resverlogix Corp.
|
Dec 21, 2020 11:37AM
|
|
Re: Bankruptcy?
|
6
|
Resverlogix Corp.
|
Dec 20, 2023 10:20AM
|
|
Re: Bear....if you could clarify....What's the bottom line?
|
5
|
Resverlogix Corp.
|
May 22, 2017 12:53PM
|
|
Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
|
4
|
Resverlogix Corp.
|
Dec 05, 2017 01:20PM
|
|
Re: BETonMACE Placebo Estimate
|
6
|
Resverlogix Corp.
|
Feb 20, 2019 11:16AM
|
|
Re: BETonMACE top line data
|
2
|
Resverlogix Corp.
|
Jan 16, 2018 07:27PM
|
|
Re: BIO CEO Slides Up
|
2
|
Resverlogix Corp.
|
Feb 12, 2019 02:23PM
|
|
Re: BIO-Europe Presentation
|
4
|
Resverlogix Corp.
|
Mar 15, 2018 08:20AM
|
|
Re: BIO-Europe Presentation is up
|
1
|
Resverlogix Corp.
|
Nov 07, 2017 12:36PM
|
|
Re: BOD AGM
|
5
|
Resverlogix Corp.
|
Jun 01, 2022 12:59PM
|
|
Re: BRD2 involvement in Covid19
|
4
|
Resverlogix Corp.
|
Mar 18, 2020 03:30PM
|
|
Re: Breakthrough Therapy Designation Application
|
4
|
Resverlogix Corp.
|
Dec 06, 2019 10:22AM
|
|
Re: Breakthrough Therapy Designation Application
|
5
|
Resverlogix Corp.
|
Dec 06, 2019 11:34AM
|
|
Re: Breakthrough Therapy Question
|
5
|
Resverlogix Corp.
|
Jan 06, 2020 07:10AM
|
|
Re: BTD
|
6
|
Resverlogix Corp.
|
Apr 23, 2022 03:10PM
|
